AutoGenomics Launches Familial Mediterranean Fever Panel, Plans FDA Submission

The firm expects to obtain a CE Mark for the assay later this quarter, and plans to eventually submit the panel to the US Food and Drug Administration for 510(k) clearance.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.